Alkermes (ALKS) Non-Current Deferred Revenue (2011 - 2022)
Alkermes (ALKS) recorded Non-Current Deferred Revenue of $6.4 million in Q3 2022, down 50.2% from $12.86 million a year earlier.
Powered by 
Analysis
Alkermes (ALKS) Non-Current Deferred Revenue (2011 - 2022) Analysis & Trends
At the end of FY2021, Alkermes reported Non-Current Deferred Revenue of $11.49 million, down 29.9% from FY2020.
- Annual Non-Current Deferred Revenue has a five-year compound annual growth rate of 10.0% (FY2016 to FY2021).
- Across earlier years, Non-Current Deferred Revenue came in at $16.4 million in FY2020 (-25.7%), $22.07 million in FY2019 (+131.7%), $9.53 million in FY2018 (+68.4%) and $5.66 million in FY2017 (-20.6%).
- The Q3 2022 figure is the lowest quarterly Non-Current Deferred Revenue since Q3 2018.
- Peak year-over-year performance for Non-Current Deferred Revenue in the last five years was growth of 131.7% in Q4 2019, against a decline of 50.2% in Q3 2022 at the low end.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,261.99 Bn | 1,235.61 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 678.93 Bn | 598.79 Bn | 17.30 Bn |
| 3 | AbbVie | 518.29 Bn | 486.30 Bn | 13.12 Bn |
| 4 | Merck | 365.98 Bn | 328.92 Bn | 13.19 Bn |
| 5 | Novartis Ag | 316.85 Bn | 290.09 Bn | - |
| 6 | Astrazeneca | 293.40 Bn | 267.29 Bn | 13.26 Bn |
| 7 | Amgen | 251.78 Bn | 203.43 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 210.61 Bn | 185.71 Bn | 6.73 Bn |
| 9 | Pfizer | 166.87 Bn | 114.23 Bn | 12.56 Bn |
| 10 | Alkermes | 7.77 Bn | 5.26 Bn | 385.91 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2022 | 6.40 Mn |
| Dec 31, 2021 | 11.49 Mn |
| Sep 30, 2021 | 12.86 Mn |
| Jun 30, 2021 | 14.17 Mn |
| Mar 31, 2021 | 14.75 Mn |
| Dec 31, 2020 | 16.40 Mn |
| Sep 30, 2020 | 18.64 Mn |
| Jun 30, 2020 | 18.88 Mn |
| Mar 31, 2020 | 21.16 Mn |
| Dec 31, 2019 | 22.07 Mn |
| Sep 30, 2019 | 11.19 Mn |
| Jun 30, 2019 | 11.62 Mn |
| Mar 31, 2019 | 11.34 Mn |
| Dec 31, 2018 | 9.53 Mn |
| Sep 30, 2018 | 5.01 Mn |
| Jun 30, 2018 | 5.86 Mn |
| Mar 31, 2018 | 6.17 Mn |
| Dec 31, 2017 | 5.66 Mn |
| Sep 30, 2017 | 6.13 Mn |
| Jun 30, 2017 | 6.78 Mn |
API Access
Alkermes Non-Current Deferred Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-current-deffered-revenue&ticker=ALKS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-current-deffered-revenue", "ticker": "ALKS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-current-deffered-revenue&ticker=ALKS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();